Hemophilia Gene Therapy Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026 © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Hemophilia Gene Therapy Market – Overview Hemophilia is a genetic disorder in which patient’s blood do not clot normally due to lack of blood-clotting proteins known as coagulating factors. Conventional treatment options include timely replacement of the specific clotting factor. Major pharma and biotech companies are conducting research and development to develop gene therapy for hemophilia due to various shortcomings with conventional therapy. Increasing number of hemophilic patients that require treatment and strong product pipeline are expected to drive growth of the hemophilia gene therapy market. Major factors that are driving growth of the hemophilia gene therapy market include increasing prevalence of hemophilia, issue of high cost, access to current hemophilia treatment, which includes coagulation factor VIII and IX, and increasing number of companies engaged in research and development of gene therapy products. According to the Centers for Disease Control and Prevention, hemophilia A is a rare, X-linked bleeding disorder that affects around 1 in 5,000 to 10,000 live-born males. Hemophilia B is less common than hemophilia A, with an incidence of around 1 in 25,000 births. High prevalence of hemophilia is increasing demand for sustainable treatment of the disease, which is projected to drive the market growth over the forecast period. According to the National Hemophilia Foundation factsheet 2018, hemophilia affected over 400,000 individuals worldwide. Moreover, according to same source, an estimated 75% of patients suffering from hemophilia have no access to treatment or receive inadequate treatment. © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Hemophilia Gene Therapy Market Taxonomy: By Type: ● Hemophilia A ● Hemophilia B By Region: ● North America ● Latin America ● Europe ● Asia Pacific Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2480 © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Hemophilia Gene Therapy Market: Key Players ● BioMarin Pharmaceuticals, Inc. ● Spark Therapeutics. ● Pfizer, Inc. ● UniQure NV ● Ultragenyx Pharmaceutical ● Shire PLC ● Sangamo Therapeutics ● Freeline Therapeutics View this report @ https://www.coherentmarketinsights.com/market-insight/hemophilia-gene-therapy-market-2480 © Coherent market Insights. All Rights Reserved ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH MARKET INTELLIGENCE SERVICES CONSULT STUDIES COUNTRY SPECIFIC STUDIES © Coherent market Insights. All Rights Reserved ABOUT COHERENT MARKET INSIGHTS SECTOR COVERAGE Healthcare CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL IMAGING PHARMACEUTICAL MEDICAL DEVICES Chemicals & Materials Bulk Chemicals Advanced Materials Speciality and Fine Chemicals Green Chemicals Food Ingredients © Coherent market Insights. All Rights Reserved Cosmetic Ingredients Polymers & Resins ABOUT COHERENT MARKET INSIGHTS KEY STATS RESEARCH SOLUTIONS FEASIBILITY STUDIES GLOBAL REPORTS 100+ Insights Published Per Year 150+ Consulting Projects Till Date 125+ Clients Worldwide Per Year 110+ COUNTRY ANALYSIS CONSULT PROJECTS SURVEY RESEARC H EXCEL FORECAST DATABASE CUSTOMIZED SOLUTIONS COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved To k no w mor e abo ut us , v is it o ur w eb site: w ww.coh er en tmark etins ig hts.com THANK YOU © Coherent market Insights. All Rights Reserved F or s ales q ueries o r new top ics email u s o n : s ales@coh er en tmark etins ig hts .co m Fo r o th er q uer ies co n tact: Mr. Sh ah ( Man ag er - Bus iness D ev elo pment) Co herent Mark et Ins ig hts s ales@coh er en tmark etins ig hts .co m +1 -2 06 -7 0 1- 67 02

Hemophilia is a genetic bleeding disorder in which an individual lacks or has low levels of proteins called clotting factors. There are around 13 types of clotting factors that work with blood platelets, which are necessary for clotting process to initiate.